3Blundell EL, Pamphilon DH, Fraser ID et al. A prospective, ran- domized study of the use of platelet concentrates irradiated with ul- traviolet-B light in patients with hematologic malignancy. Transfu- sion, 1996,36 (4) : 296 -302.
4Mohanty D. Current concepts in platelet transfusion. Asian J Trans- fus Sci,2009,3 ( 1 ) :18-21.
5Bode AP. Platelet activation may explain the storage lesion in plate- let concentrates. Blood Ceils, 1990,16( 1 ) :109-126.
6Bode AP, Knupp CL, Miller DT. Effect of platelet activation inhibi- tors on the loss of glycoprotein I b during storage of platelet con- centrates. J Lab Clin Med, 1990,115 ( 6 ) :669-679.
7Bode AP, Eick L. Lysed platelets shorten the activated coagulation time (ACT) of heparinized blood. Am J Clin Pathol, 1989,91 (4) : 430-434.
8Read MS, Red.dick RL, Bode AP, et al, Preservation of hemostatic : potential for long-term storage of dried platelet for transfusion. Proc Nail Acad Sci USA,1995,92(期次?) :397-401.
9Schubert P, Devine DV De novo protein synthesis in mature plate- lets:a consideration for transfusion medicine. Vox Sang, 2010,99 (2) :112-122.
10Brox JH, Osterud B. Evidence for appearance of lysis independent proeoagulant activities in collagen or thrombln stimulated platelets. Thromb Res, 1983,30:5 ( 5 ) 449 -458.
